Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 May;63(5):753–757. doi: 10.1038/bjc.1991.168

Multiple sequential molecular abnormalities in the evolution of human gliomas.

D J Venter 1, D G Thomas 1
PMCID: PMC1972386  PMID: 1674878

Abstract

We have examined a series of 13 benign and 27 malignant human gliomas for evidence of molecular abnormalities of proto-oncogene and putative tumour suppressor gene loci. The results indicated that specific molecular lesions were associated with increasing grades of malignancy. Thus, loss of genetic material on chromosome 17 was present with approximately equal frequency in both benign and malignant gliomas, whereas loss of loci on chromosome 10 was seen only in malignant gliomas. Only the most malignant tumours, known as glioblastoma multiforme, had more than one molecular abnormality in the same tumour. These findings may contribute to our understanding of glial tumour development, as well as improve the accuracy of tumour diagnosis.

Full text

PDF
753

Images in this article

755Figure 1
on p.755
755Figure 2
on p.755
756Figure 3
on p.756

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker S. J., Fearon E. R., Nigro J. M., Hamilton S. R., Preisinger A. C., Jessup J. M., vanTuinen P., Ledbetter D. H., Barker D. F., Nakamura Y. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989 Apr 14;244(4901):217–221. doi: 10.1126/science.2649981. [DOI] [PubMed] [Google Scholar]
  2. Bigner S. H., Mark J., Bullard D. E., Mahaley M. S., Jr, Bigner D. D. Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations. Cancer Genet Cytogenet. 1986 Jun;22(2):121–135. doi: 10.1016/0165-4608(86)90172-x. [DOI] [PubMed] [Google Scholar]
  3. Bishop J. M. Cellular oncogenes and retroviruses. Annu Rev Biochem. 1983;52:301–354. doi: 10.1146/annurev.bi.52.070183.001505. [DOI] [PubMed] [Google Scholar]
  4. Carlson M., Nakamura Y., Payson R., O'Connell P., Leppert M., Lathrop G. M., Lalouel J. M., White R. Isolation and mapping of a polymorphic DNA sequence pMCT35.1 on chromosome 17p [D17S31]. Nucleic Acids Res. 1988 Jan 25;16(2):783–783. doi: 10.1093/nar/16.2.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cavenee W. K., Dryja T. P., Phillips R. A., Benedict W. F., Godbout R., Gallie B. L., Murphree A. L., Strong L. C., White R. L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. 1983 Oct 27-Nov 2Nature. 305(5937):779–784. doi: 10.1038/305779a0. [DOI] [PubMed] [Google Scholar]
  6. Cooper J. A., Whyte P. RB and the cell cycle: entrance or exit? Cell. 1989 Sep 22;58(6):1009–1011. doi: 10.1016/0092-8674(89)90495-9. [DOI] [PubMed] [Google Scholar]
  7. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  8. Finlay C. A., Hinds P. W., Levine A. J. The p53 proto-oncogene can act as a suppressor of transformation. Cell. 1989 Jun 30;57(7):1083–1093. doi: 10.1016/0092-8674(89)90045-7. [DOI] [PubMed] [Google Scholar]
  9. Fujimoto M., Fults D. W., Thomas G. A., Nakamura Y., Heilbrun M. P., White R., Story J. L., Naylor S. L., Kagan-Hallet K. S., Sheridan P. J. Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics. 1989 Feb;4(2):210–214. doi: 10.1016/0888-7543(89)90302-9. [DOI] [PubMed] [Google Scholar]
  10. Garson J. A., McIntyre P. G., Kemshead J. T. N-myc amplification in malignant astrocytoma. Lancet. 1985 Sep 28;2(8457):718–719. doi: 10.1016/s0140-6736(85)92950-2. [DOI] [PubMed] [Google Scholar]
  11. James C. D., Carlbom E., Dumanski J. P., Hansen M., Nordenskjold M., Collins V. P., Cavenee W. K. Clonal genomic alterations in glioma malignancy stages. Cancer Res. 1988 Oct 1;48(19):5546–5551. [PubMed] [Google Scholar]
  12. James C. D., Carlbom E., Nordenskjold M., Collins V. P., Cavenee W. K. Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2858–2862. doi: 10.1073/pnas.86.8.2858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Knudson A. G., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lamb P., Crawford L. Characterization of the human p53 gene. Mol Cell Biol. 1986 May;6(5):1379–1385. doi: 10.1128/mcb.6.5.1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Land H., Parada L. F., Weinberg R. A. Cellular oncogenes and multistep carcinogenesis. Science. 1983 Nov 18;222(4625):771–778. doi: 10.1126/science.6356358. [DOI] [PubMed] [Google Scholar]
  16. Libermann T. A., Nusbaum H. R., Razon N., Kris R., Lax I., Soreq H., Whittle N., Waterfield M. D., Ullrich A., Schlessinger J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature. 1985 Jan 10;313(5998):144–147. doi: 10.1038/313144a0. [DOI] [PubMed] [Google Scholar]
  17. Litt M., Mueller O. T., Shows T. B., Litt R. A single copy subclone, p1-101, from cosmid 3-3B, defines three RFLPs on 10pter-q23 [HGM9 no. D10S4]. Nucleic Acids Res. 1987 Mar 25;15(6):2783–2783. doi: 10.1093/nar/15.6.2783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Masuda H., Miller C., Koeffler H. P., Battifora H., Cline M. J. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7716–7719. doi: 10.1073/pnas.84.21.7716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. McComb R. D., Bigner D. D. The biology of malignant gliomas--a comprehensive survey. Clin Neuropathol. 1984 May-Jun;3(3):93–106. [PubMed] [Google Scholar]
  20. McDermid H. E., Goodfellow P. J., Duncan A. M., Brasch K. R., Simpson N. E., Souza C. D., Holden J. J., White B. N. A polymorphic locus, D10S5, at 10q21.1. Nucleic Acids Res. 1987 Jul 10;15(13):5498–5498. doi: 10.1093/nar/15.13.5498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nakamura Y., Leppert M., O'Connell P., Wolff R., Holm T., Culver M., Martin C., Fujimoto E., Hoff M., Kumlin E. Variable number of tandem repeat (VNTR) markers for human gene mapping. Science. 1987 Mar 27;235(4796):1616–1622. doi: 10.1126/science.3029872. [DOI] [PubMed] [Google Scholar]
  22. Pearson P. L., Kidd K. K., Willard H. F. Report of the committee on human gene mapping by recombinant DNA techniques. Cytogenet Cell Genet. 1987;46(1-4):390–566. doi: 10.1159/000132487. [DOI] [PubMed] [Google Scholar]
  23. Raeymaekers P., Van Broeckhoven C., Vandenberghe A. Two polymorphic loci are detected simultaneously by probe CARLP II8.2 [D10S21] on chromosome 10. Nucleic Acids Res. 1988 Mar 25;16(6):2738–2738. doi: 10.1093/nar/16.6.2738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rey J. A., Bello M. J., de Campos J. M., Kusak M. E., Moreno S. Chromosomal composition of a series of 22 human low-grade gliomas. Cancer Genet Cytogenet. 1987 Dec;29(2):223–237. doi: 10.1016/0165-4608(87)90233-0. [DOI] [PubMed] [Google Scholar]
  25. Schechter A. L., Stern D. F., Vaidyanathan L., Decker S. J., Drebin J. A., Greene M. I., Weinberg R. A. The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature. 1984 Dec 6;312(5994):513–516. doi: 10.1038/312513a0. [DOI] [PubMed] [Google Scholar]
  26. Schwab M., Alitalo K., Klempnauer K. H., Varmus H. E., Bishop J. M., Gilbert F., Brodeur G., Goldstein M., Trent J. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature. 1983 Sep 15;305(5931):245–248. doi: 10.1038/305245a0. [DOI] [PubMed] [Google Scholar]
  27. Sebastio G., Riccio A., Verde P., Scarpato N., Blasi F. BamHI RFLP linked to the human urokinase gene. Nucleic Acids Res. 1985 Jul 25;13(14):5404–5404. doi: 10.1093/nar/13.14.5404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Slamon D. J., Godolphin W., Jones L. A., Holt J. A., Wong S. G., Keith D. E., Levin W. J., Stuart S. G., Udove J., Ullrich A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989 May 12;244(4905):707–712. doi: 10.1126/science.2470152. [DOI] [PubMed] [Google Scholar]
  29. Solomon E., Hiorns L., Sheer D., Rowe D. Confirmation that the type I collagen gene on chromosome 17 is COL1A1 (alpha 1(I), using a human genomic probe. Ann Hum Genet. 1984 Jan;48(Pt 1):39–42. doi: 10.1111/j.1469-1809.1984.tb00831.x. [DOI] [PubMed] [Google Scholar]
  30. Sykes B., Solomon E. Assignment of a type I collagen structural gene to human chromosome 7. Nature. 1978 Apr 6;272(5653):548–549. doi: 10.1038/272548a0. [DOI] [PubMed] [Google Scholar]
  31. T'Ang A., Varley J. M., Chakraborty S., Murphree A. L., Fung Y. K. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science. 1988 Oct 14;242(4876):263–266. doi: 10.1126/science.3175651. [DOI] [PubMed] [Google Scholar]
  32. Ullrich A., Coussens L., Hayflick J. S., Dull T. J., Gray A., Tam A. W., Lee J., Yarden Y., Libermann T. A., Schlessinger J. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. 1984 May 31-Jun 6Nature. 309(5967):418–425. doi: 10.1038/309418a0. [DOI] [PubMed] [Google Scholar]
  33. Venter D. J., Tuzi N. L., Kumar S., Gullick W. J. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet. 1987 Jul 11;2(8550):69–72. doi: 10.1016/s0140-6736(87)92736-x. [DOI] [PubMed] [Google Scholar]
  34. Vogelstein B., Fearon E. R., Hamilton S. R., Kern S. E., Preisinger A. C., Leppert M., Nakamura Y., White R., Smits A. M., Bos J. L. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988 Sep 1;319(9):525–532. doi: 10.1056/NEJM198809013190901. [DOI] [PubMed] [Google Scholar]
  35. Weinberg R. A. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res. 1989 Jul 15;49(14):3713–3721. [PubMed] [Google Scholar]
  36. Wong Z., Wilson V., Patel I., Povey S., Jeffreys A. J. Characterization of a panel of highly variable minisatellites cloned from human DNA. Ann Hum Genet. 1987 Oct;51(Pt 4):269–288. doi: 10.1111/j.1469-1809.1987.tb01062.x. [DOI] [PubMed] [Google Scholar]
  37. Yokota J., Yamamoto T., Toyoshima K., Terada M., Sugimura T., Battifora H., Cline M. J. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet. 1986 Apr 5;1(8484):765–767. doi: 10.1016/s0140-6736(86)91782-4. [DOI] [PubMed] [Google Scholar]
  38. el-Azouzi M., Chung R. Y., Farmer G. E., Martuza R. L., Black P. M., Rouleau G. A., Hettlich C., Hedley-Whyte E. T., Zervas N. T., Panagopoulos K. Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7186–7190. doi: 10.1073/pnas.86.18.7186. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES